{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T05:40:14Z","timestamp":1730007614075,"version":"3.28.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,26]]},"DOI":"10.7759\/cureus.72452","type":"journal-article","created":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T05:17:47Z","timestamp":1730006267000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Sarcopenia by Psoas Muscle Measurements in Bullous Pemphigoid: A Single-Institution Survey in Japan"],"prefix":"10.7759","author":[{"given":"Yu","family":"Matsui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruhiko","family":"Makino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadamichi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00220","article-title":"The growing incidence of bullous pemphigoid: overview and potential explanations","volume":"5","author":"Kridin K","year":"2018","unstructured":"Kridin K, Ludwig RJ. The growing incidence of bullous pemphigoid: overview and potential explanations. Front Med (Lausanne). 2018, 5:220. 10.3389\/fmed.2018.00220","journal-title":"Front Med (Lausanne)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15111","article-title":"Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita)","volume":"46","author":"Ujiie H","year":"2019","unstructured":"Ujiie H, Iwata H, Yamagami J, et al.. Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita). J Dermatol. 2019, 46:1102-35. 10.1111\/1346-8138.15111","journal-title":"J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu D","year":"2013","unstructured":"Liu D, Ahmet A, Ward L, et al.. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013, 9:30. 10.1186\/1710-1492-9-30","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref4","article-title":"Clinical definition of sarcopenia","volume":"11","author":"Santilli V","year":"2014","unstructured":"Santilli V, Bernetti A, Mangone M, Paoloni M. Clinical definition of sarcopenia. Clin Cases Miner Bone Metab. 2014, 11:177-80.","journal-title":"Clin Cases Miner Bone Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2022.12.002","article-title":"Psoas muscle index: a simple and reliable method of sarcopenia assessment on computed tomography scan in chronic liver disease and its impact on mortality","volume":"13","author":"Rodge GA","year":"2023","unstructured":"Rodge GA, Goenka U, Jajodia S, Agarwal R, Afzalpurkar S, Roy A, Goenka MK. Psoas muscle index: a simple and reliable method of sarcopenia assessment on computed tomography scan in chronic liver disease and its impact on mortality. J Clin Exp Hepatol. 2023, 13:196-202. 10.1016\/j.jceh.2022.12.002","journal-title":"J Clin Exp Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S416778","article-title":"Association between autoimmune diseases and sarcopenia: a two-sample Mendelian randomization study","volume":"15","author":"Su Q","year":"2023","unstructured":"Su Q, Jin C, Yang Y, et al.. Association between autoimmune diseases and sarcopenia: a two-sample Mendelian randomization study. Clin Epidemiol. 2023, 15:901-10. 10.2147\/CLEP.S416778","journal-title":"Clin Epidemiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3391","article-title":"Dipeptidyl peptidase-4 inhibitor treatment and the risk of bullous pemphigoid and skin-related adverse events: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Yang W","year":"2021","unstructured":"Yang W, Cai X, Zhang S, Han X, Ji L. Dipeptidyl peptidase-4 inhibitor treatment and the risk of bullous pemphigoid and skin-related adverse events: a systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Res Rev. 2021, 37:e3391. 10.1002\/dmrr.3391","journal-title":"Diabetes Metab Res Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19026","article-title":"Individual meta-analysis of vital prognostic factors of patients with bullous pemphigoid","volume":"37","author":"Tedbirt B","year":"2023","unstructured":"Tedbirt B, Joly P, Gillibert A. Individual meta-analysis of vital prognostic factors of patients with bullous pemphigoid. J Eur Acad Dermatol Venereol. 2023, 37:e917-9. 10.1111\/jdv.19026","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111082","article-title":"Risk factors predisposing relapse of bullous pemphigoid at initial diagnosis: A retrospective cohort study of 205 patients","volume":"125","author":"Liu Y","year":"2023","unstructured":"Liu Y, Wang Y, Zhang J, et al.. Risk factors predisposing relapse of bullous pemphigoid at initial diagnosis: A retrospective cohort study of 205 patients. Int Immunopharmacol. 2023, 125:111082. 10.1016\/j.intimp.2023.111082","journal-title":"Int Immunopharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2016.04.003","article-title":"Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults","volume":"32","author":"Hamaguchi Y","year":"2016","unstructured":"Hamaguchi Y, Kaido T, Okumura S, et al.. Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults. Nutrition. 2016, 32:1200-5. 10.1016\/j.nut.2016.04.003","journal-title":"Nutrition"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda Y","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013, 48:452-8. 10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12783","article-title":"Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis","volume":"13","author":"Petermann-Rocha F","year":"2022","unstructured":"Petermann-Rocha F, Balntzi V, Gray SR, Lara J, Ho FK, Pell JP, Celis-Morales C. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022, 13:86-99. 10.1002\/jcsm.12783","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12651","article-title":"Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults","volume":"12","author":"Kitamura A","year":"2021","unstructured":"Kitamura A, Seino S, Abe T, et al.. Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults. J Cachexia Sarcopenia Muscle. 2021, 12:30-8. 10.1002\/jcsm.12651","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2010.11.002","article-title":"Inflammatory markers in population studies of aging","volume":"10","author":"Singh T","year":"2011","unstructured":"Singh T, Newman AB. Inflammatory markers in population studies of aging. Ageing Res Rev. 2011, 10:319-29. 10.1016\/j.arr.2010.11.002","journal-title":"Ageing Res Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2019.100980","article-title":"Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis","volume":"56","author":"Livshits G","year":"2019","unstructured":"Livshits G, Kalinkovich A. Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis. Ageing Res Rev. 2019, 56:100980. 10.1016\/j.arr.2019.100980","journal-title":"Ageing Res Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00107.x","article-title":"Epitope spreading: lessons from autoimmune skin diseases","volume":"110","author":"Chan LS","year":"1998","unstructured":"Chan LS, Vanderlugt CJ, Hashimoto T, et al.. Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol. 1998, 110:103-9. 10.1046\/j.1523-1747.1998.00107.x","journal-title":"J Invest Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117919","article-title":"The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model","volume":"95","author":"Ghadially R","year":"1995","unstructured":"Ghadially R, Brown BE, Sequeira-Martin SM, Feingold KR, Elias PM. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Invest. 1995, 95:2281-90. 10.1172\/JCI117919","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.11.006","article-title":"Inflammaging and the skin","volume":"141","author":"Pilkington SM","year":"2021","unstructured":"Pilkington SM, Bulfone-Paus S, Griffiths CE, Watson RE. Inflammaging and the skin. J Invest Dermatol. 2021, 141:1087-95. 10.1016\/j.jid.2020.11.006","journal-title":"J Invest Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2020.11.002","article-title":"A single-cell transcriptomic atlas of human skin aging","volume":"56","author":"Zou Z","year":"2021","unstructured":"Zou Z, Long X, Zhao Q, et al.. A single-cell transcriptomic atlas of human skin aging. Dev Cell. 2021, 56:383-397.e8. 10.1016\/j.devcel.2020.11.002","journal-title":"Dev Cell"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16654","article-title":"What's new in the pathogeneses and triggering factors of bullous pemphigoid","volume":"50","author":"Ujiie H","year":"2023","unstructured":"Ujiie H. What's new in the pathogeneses and triggering factors of bullous pemphigoid. J Dermatol. 2023, 50:140-9. 10.1111\/1346-8138.16654","journal-title":"J Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2013.05.009","article-title":"Proinflammatory cytokines, aging, and age-related diseases","volume":"14","author":"Michaud M","year":"2013","unstructured":"Michaud M, Balardy L, Moulis G, et al.. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc. 2013, 14:877-82. 10.1016\/j.jamda.2013.05.009","journal-title":"J Am Med Dir Assoc"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afx088","article-title":"Grip strength and inflammatory biomarker profiles in very old adults","volume":"46","author":"Granic A","year":"2017","unstructured":"Granic A, Davies K, Martin-Ruiz C, Jagger C, Kirkwood TB, von Zglinicki T, Aihie Sayer A. Grip strength and inflammatory biomarker profiles in very old adults. Age Ageing. 2017, 46:976-82. 10.1093\/ageing\/afx088","journal-title":"Age Ageing"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-017-0266-9","article-title":"A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-\u03b1","volume":"22","author":"Bian AL","year":"2017","unstructured":"Bian AL, Hu HY, Rong YD, Wang J, Wang JX, Zhou XZ. A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-\u03b1. Eur J Med Res. 2017, 22:25. 10.1186\/s40001-017-0266-9","journal-title":"Eur J Med Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2174\/0929867326666181129095309","article-title":"Role of pro-inflammatory cytokines in regulation of skeletal muscle metabolism: a systematic review","volume":"27","author":"Sharma B","year":"2020","unstructured":"Sharma B, Dabur R. Role of pro-inflammatory cytokines in regulation of skeletal muscle metabolism: a systematic review. Curr Med Chem. 2020, 27:2161-88. 10.2174\/0929867326666181129095309","journal-title":"Curr Med Chem"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/312129-evaluation-of-sarcopenia-by-psoas-muscle-measurements-in-bullous-pemphigoid-a-single-institution-survey-in-japan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T05:17:49Z","timestamp":1730006269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/312129-evaluation-of-sarcopenia-by-psoas-muscle-measurements-in-bullous-pemphigoid-a-single-institution-survey-in-japan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,26]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.72452","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,26]]}}}